Page last updated: 2024-12-06

2,2',3',4,4',5-hexachlorobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,2',3',4,4',5-hexachlorobiphenyl (PCB 153) is a persistent organic pollutant (POP) that is highly resistant to degradation in the environment. It is a colorless, odorless solid that is not readily soluble in water. It is synthesized through the chlorination of biphenyl. PCBs were widely used in industrial applications such as electrical insulation, hydraulic fluids, and heat transfer fluids. However, due to their persistence, bioaccumulation, and toxic effects, they are now banned in many countries. PCB 153 is known to be an endocrine disruptor, meaning it can interfere with the hormonal system of animals and humans. It has been linked to reproductive problems, developmental delays, and cancer. It is studied extensively because of its environmental persistence, bioaccumulation, and potential health risks. '
```

Cross-References

ID SourceID
PubMed CID37035
CHEBI ID165219
SCHEMBL ID4459622
MeSH IDM0094791

Synonyms (39)

Synonym
1,1'-biphenyl, 2,2',3,4,4',5'-hexachloro-
2,2',3,4,4',5'-hexachlorobiphenyl
inchi=1/c12h4cl6/c13-7-2-1-5(11(17)12(7)18)6-3-9(15)10(16)4-8(6)14/h1-4
2,2',3',4,4',5-hexachlorobiphenyl
ccris 4039
2,2,'3,4,4,'5'-hexachlorobiphenyl
35065-28-2
pcb 138
pcb-138
pcb138
2,3,4,2',4',5'-hexachlorobiphenyl
CHEBI:165219
1,2,3-trichloro-4-(2,4,5-trichlorophenyl)benzene
unii-7y6jig1867
7y6jig1867 ,
pcb no 138
1,1'-biphenyl,2,2',3,4,4',5'-hexachloro-
SCHEMBL4459622
RPUMZMSNLZHIGZ-UHFFFAOYSA-N
2,2',3,4,4',5'-hexachloro-1,1'-biphenyl #
DTXSID8038300 ,
2,2',3,4,4',5'-hexachlorobiphenyl (iupac no. 138), bcr(r) certified reference material
2,2',3,4,4',5'-hexachlorobiphenyl (iupac no. 138)
pcb no 138, analytical standard
2,2',3,4,4',5'-hexachlorobiphenyl, 99%, vial of 25 mg, bz# 138
2,2',3,4,4',5'-hexachlorobiphenyl, 99%, vial of 250 mg, bz# 138, analytical standard
pcb no. 138 10 microg/ml in isooctane
pcb no. 138
J-019851
2,2',3,4,4',5'-hexachloro-1,1'-biphenyl
pcb no. 138 100 microg/ml in hexane
pcb no. 138 100 microg/ml in isooctane
Q27269013
2,2',3,4,4',5'-hexachlorbiphenyl
1ST3737
dtxcid6018300
19d - polychlorinated biphenyls
contest group c reduced
07d - polychlorinated biphenyls

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Perturbations of these endpoints are described as common key events in adverse outcome pathways (AOPs) specific for DNT."( Combining in vitro assays and mathematical modelling to study developmental neurotoxicity induced by chemical mixtures.
Bal-Price, A; Bopp, SK; Carpi, D; Mendoza-de Gyves, E; Paini, A; Pistollato, F; Worth, A, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
polychlorobiphenylA biphenyl compound containing between 2 and 10 chlorine atoms attached to the two benzene rings.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.13)18.7374
1990's2 (4.26)18.2507
2000's6 (12.77)29.6817
2010's37 (78.72)24.3611
2020's1 (2.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.11 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.13%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.13%)4.05%
Observational0 (0.00%)0.25%
Other45 (95.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]